Jim Cramer on Amazon: 'It's a Huge Position for My Charitable Trust'
'Alright, now on Monday, we have a very special interview with Andy Jassy. He's the CEO of Amazon. It's a huge position for my Charitable Trust. We'll talk about everything from investments in rural delivery to new and improved Alexa to the growth of Amazon Web Services, the juicy gross margins of Amazon advertising, and why we love being Prime members. Given its retail presence, Amazon's got a great read on the consumer. Its international business seems to have turned the corner.
A customer entering an internet retail store, illustrating the convenience of online shopping.
Amazon.com, Inc. (NASDAQ:AMZN) provides a broad range of retail, digital, and cloud services, including product sales, subscriptions, advertising, and media content.
While we acknowledge the potential of AMZN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.
Disclosure: None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
Why Nektar Therapeutics Stock Dived by 3% Today
The company announced it closed its latest capital-raising effort. This took the form of a nearly 5-million strong, secondary share issue. 10 stocks we like better than Nektar Therapeutics › Nektar Therapeutics (NASDAQ: NKTR) saw its stock price erode on Thursday, following the company's closing of a secondary stock issue. Investors gave the company a thumbs-down on the news by selling out of its shares, leaving it with a 3% loss at the close of trading. Meanwhile, the benchmark S&P 500 index ticked up on the day, rising by 0.8%. Just after market hours on Wednesday, Nektar announced that it completed that new share flotation. The clinical-stage biotech sold slightly more than 4.89 million shares of its common stock. Within that number were 638,298 that were sold to the underwriters of the issue. Collectively, those entities fully exercised their option to buy Nektar stock. The gross proceeds of the issue, which was priced at $23.50 per share, amounted to roughly $115 million. Nektar wrote that it aims to deploy the new funds for "general corporate purposes," which might include drug development and manufacturing, and research and development activities. As often happens with secondary share flotations, particularly in the frequently cash-hungry biotech space, this one is notably dilutive to existing shareholders. Prior to this issue, Nektar had slightly more than 12.4 million common shares outstanding. So that nearly 5 million share-count addition is going to make a difference -- and not in a positive way. At least the money is being raised by a business with potential. Relatively speaking, Nektar has quite a few pipeline projects in development. Its leading one, rezpegaldesleukin, recently tested quite well for treating moderate-to-severe atopic dermatitis, a skin disorder. That said, the new shares are weighing on the company, and investors are probably worried that more equity offerings are coming, hence more dilution. While a company's share count shouldn't be the only consideration when evaluating a stock, it does matter, and this latest one from Nektar has sparked concern. Before you buy stock in Nektar Therapeutics, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Nektar Therapeutics wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $692,914!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $963,866!* Now, it's worth noting Stock Advisor's total average return is 1,049% — a market-crushing outperformance compared to 179% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Nektar Therapeutics Stock Dived by 3% Today was originally published by The Motley Fool Sign in to access your portfolio
Time Magazine
14 minutes ago
- Time Magazine
Trump's ‘Big Beautiful Bill' Cements GOP Dominance
The passage of the 'Big Beautiful Bill' on Thursday was a moment when President Donald Trump's hold on the Republican Party was tested — and he won. GOP holdouts objected to the trillions of dollars the bill is projected to add to the debt and the cuts to Medicaid and other safety net programs. But in the end, Trump was able to browbeat Republicans into supporting his costly plans to fund long-term tax cuts for the wealthy, more deportations of immigrants and boosting defense spending. Trump's victory further strengthens his power in Washington and clears the way for him to take even more aggressive actions on immigration, trade policy and depart from American tradition to hammer the chair of the Federal Reserve Jerome Powell into lowering interest rates, a move that could give the U.S. economy a sugar high of cheap cash. Trump's control over the GOP 'is as close to total as any President has ever had over his own political party,' says Whit Ayres, a long-time Republican pollster. 'It gives him the support of his own legislative caucus for almost anything he wants to do.' Trump plans to sign the bill into law on Friday at 5 p.m. as B-2 bombers jet over the White House during a Fourth of July celebration for military families. 'We'll be signing with those beautiful planes flying right over our heads,' Trump told reporters traveling with him on Air Force One on Thursday evening. In order to get the bill passed, some Republicans broke their promises not to cut Medicaid, other Republicans reneged on pledges to keep down the national debt. In the House, only two Republicans—Rep. Thomas Massie of Kentucky and Rep. Brian Fitzpatrick of Pennsylvania—ended up voting against Trump's bill. The bill narrowly passed the House 218-214 with all Democrats voting against it. Massie wrote on X that he voted 'no' because 'it will significantly increase U.S. budget deficits in the near term, negatively impacting all Americans through sustained inflation and high interest rates.' The bill barely made it out of the Senate earlier in the week. Republican Senators Susan Collins of Maine, Rand Paul of Kentucky and Thom Tillis of North Carolina voted against Trump's bill forcing Vice President J.D. Vance to cast a tie-breaking vote. Tillis said the Medicaid cuts would be devastating to his state, and, after bucking Trump, said he wouldn't run for reelection. Republican Senator Josh Hawley of Missouri had argued against the cuts to Medicaid but ended up voting 'yes,' and Senator Ron Johnson of Wisconsin, a Republican, had criticized the bill for not cutting enough to offset adding trillions to the debt, but ended up voting for the bill. Now Trump is faced with the daunting task of selling the unpopular bill to the public. Only 29% of voters said they support the bill, according to a Quinnipiac University poll published on June 26, while 55% percent of voters said that they oppose the bill and 16% were unsure. The cuts to social safety net programs and the increase in the deficit could lead to political blowback that helps Democrats take back control of the House in the 2026 mid-term elections. The bill could be a political risk for Trump, says Ayres, if 'a whole lot of Trump supporters lose their health care and get angry about it.'
Politico
14 minutes ago
- Politico
How Scold-and-Fold Became the GOP's Calling Card
At 6:50 PM on Wednesday, conservative hardliner Rep. Keith Self (R-Texas) tweeted that the Senate's version of the Republican megabill was 'morally and fiscally bankrupt.' At 3:20 AM Thursday morning, Self nevertheless voted to advance that very bill. Rep. Chip Roy (R-Texas) likewise slammed the Senate amendments as a 'travesty' that undermined 'the good things' in the House bill. He, too, joined Self in finally supporting the legislation in the wee hours Thursday morning. Both held out longer than their moderate colleague Rep. David Valadao (R-Calif.), who said in a post on X last week that he could not vote for any Senate changes to the Medicaid provisions in the House version of the bill. These reversals may be surprising, but they were not remarkable. It was par for the course for congressional Republicans who, in recent years, have shown a proclivity for taking bold, theatrical stands before meekly capitulating in the face of political pressure — particularly from President Donald Trump. In just the past six months, hardline conservatives have expressed concerns about backing a continuing resolution, two different budget resolutions and the initial House version of the Republican megabill before caving in to pressure from Trump. In May, conservatives originally threatened to withhold their vote for the 'One Big Beautiful Bill' because it provided a tax deduction targeted at residents of blue states. The head of the House Freedom Caucus, Rep. Andy Harris (R-Md.), even insisted it might take weeks to appease hard-right concerns on May 21. It passed early in the morning the next day after hard right conservatives yielded overnight. It was no different this week when they loudly and repeatedly expressed horror and dismay at the version of the 'One Big Beautiful Bill' passed by the Senate. There was outrage that it increased the deficit. Complaints that it didn't do enough to roll back efforts to encourage clean energy were abundant. Conservatives wanted changes to the bill to address these concerns. The problem is that it would have required the bill to be sent back to the Senate, either through legislative 'ping pong' or through the traditional expedient of a conference committee. That would have been time consuming — and prevented Republicans from passing the legislation by Trump's self-imposed July 4 deadline. Republicans had until the end of the year to do the most urgent part of the legislation, the extension of the 2017 tax cuts, but the decision was made to treat Trump's deadline as a firm time limit in the same way Congress might handle the looming debt crisis or the expiration of government funding. On Wednesday morning, Rep. Tim Burchett (R-Tenn.), who railed against the imposition of 'arbitrary deadlines,' told POLITICO those kinds of deadlines led to 'panicking' and it wasn't going to work. Needless to say, Burchett eventually voted for the bill, too. The truth is that there really wasn't any other option but to stick to an arbitrary deadline, because it's what Trump wanted. Steve Scalise, the number two House Republican, bluntly explained that extending the deadline to make last-minute alterations wasn't going to happen because Trump didn't want it. 'It became clear from the president's meeting at the White House to further conversations later, that there's going to be no more amendments to the bill,' he said. Republican Rep. Troy Nehls (R-Texas) analogized the situation to a restive football team that occasionally forgets who is calling the plays and needs a reminder. 'You may be a good receiver, you may be an all star running back, but the quarterback is still Donald J. Trump.' When it was all over, the holdouts justified the Big Fold in predictable fashion, claiming to have won valuable concessions even if none of those would be enacted into law. Burchett, one of the holdouts who eventually capitulated, said that he had 'a very good conversation with President Trump and Vice President Vance.' That discussion gave him confidence that the administration would 'go after fraud and get rid of a lot of the nonsense in our energy policies.' Harris, another holdout, told reporters, 'we came to significant agreements with the administration overnight on executive actions that will make America great again.' Rep. Lloyd Smucker (R-Pa.), who long expressed concern about the deficit implications of the legislation — which by a nonpartisan Congressional Budget Office estimate will add at least $3.3 trillion to the national debt over the next decade — the process represented a combination of policy negotiation and airing of grievances. 'It was a little bit of hearing people out,' said the ardent fiscal hawk. But there were also policy issues as 'everyone became convinced it just didn't make sense to send it back to the Senate.' A more jaundiced and skeptical view was taken by Rep. William Timmons (R-S.C.), who described the dramatic scold-and-fold as a venting exercise by the usual suspects who always 'cry wolf.' 'There's just a couple people that really want to talk a lot about things that are important to them, and they use these pressure points as opportunities to force people to listen to them,' said the four-term incumbent. 'I don't think you accomplish much, but we got it done.' In the final hours before the House narrowly passed the sweeping legislation, despite all the apocalyptic rhetoric about the bill's drawback, all was forgotten and forgiven. The group of conservative holdouts, including Self and Roy, gathered in the center aisle of the House at about 3:15 in the morning. The dozen hardliners, who did not want to support the Senate bill as written, joined together for a smiling group picture just before they all cast their votes to help make that text the law of land. The photographer, using a cell phone camera, was Speaker Mike Johnson himself. 'He just pulled out his camera and we took the picture,' said Rep. Bob Onder (R-Mo.), one of the hardliners who yielded. 'It was awesome.' The Republican holdouts had ended their fight by getting together to strike a pose. It wasn't difficult. After all, they had been posing all week.
